Illinois Lab Owner Accused of Falsifying COVID-19 Tests for Federal Reimbursement

Key Takeaways

• Federal prosecutors allege a $66.2 million COVID-19 testing fraud scheme. An Illinois laboratory owner allegedly fabricated at least 380 000 negative polymerase chain reaction (PCR) test results for tests that were never performed and submitted fraudulent claims to the Health Resources and Services Administration (HRSA) Uninsured Program.
• Approximately $44.1 million in federal payments is implicated. The laboratory allegedly received $44.1 million in improper reimbursements, while the defendant personally obtained approximately $28 million in proceeds.
• The case underscores federal scrutiny of health care billing practices. The 5-count wire fraud indictment highlights potential criminal penalties associated with fraudulent reimbursement claims and the importance of accurate documentation in government-funded health care programs.

An Illinois clinical laboratory owner has been charged in connection with an alleged $66.2 million COVID-19 testing fraud scheme involving hundreds of thousands of tests that were never performed, according to the US Department of Justice (DOJ). The indictment alleges that the laboratory submitted fraudulent claims to a federally funded testing program for uninsured individuals, resulting in approximately $44.1 million in improper payments.

A federal grand jury in the Northern District of Illinois returned an indictment on October 19, 2026, charging Rajesh “Raj” Patel, 52, of Schaumburg, Illinois, with 5 counts of wire fraud. Patel allegedly fabricated COVID-19 test results to obtain federal reimbursements during the pandemic.

Alleged Scheme Involved 380 000 Fabricated COVID-19 Test Results

According to court documents, Patel was the co-owner and chief operating officer of a clinical laboratory in Hillside, Illinois, that processed PCR tests during the COVID-19 pandemic.

In approximately March 2021, the laboratory entered into an agreement with Meridian Medical Staffing Inc (Meridian) to collect test specimens and provide corresponding patient information. The laboratory paid Meridian tens of millions of dollars for these services.

However, prosecutors allege that many of the purported patients either did not exist or had never provided test specimens to Meridian.

Between May 2021 and April 2022, Patel allegedly generated false negative results for at least 380 000 PCR tests that the laboratory never performed.

The fabricated results were allegedly used to submit reimbursement claims to the HRSA Uninsured Program, a federally funded initiative established to cover COVID-19 testing costs for individuals without health insurance.

Federal Program Paid Approximately $44.1 Million in Fraudulent Claims

According to the DOJ, Patel's laboratory submitted approximately $66.2 million in fraudulent claims to HRSA, of which approximately $44.1 million was paid.

Prosecutors allege that Patel personally received approximately $28 million in proceeds from the scheme.

“This defendant allegedly exploited a global crisis for personal gain, fabricating hundreds of thousands of COVID-19 tests—then billing the taxpayer for it,” said Assistant Attorney General Colin M. McDonald of the DOJ's Fraud Division.

McDonald emphasized the department's commitment to prosecuting individuals accused of defrauding federal health care programs.

Wire Fraud Charges and Potential Penalties

Patel faces 5 counts of wire fraud, each carrying a maximum potential sentence of 20 years in federal prison if convicted.

The FBI Chicago Field Office and the US Department of Health and Human Services Office of Inspector General (HHS-OIG) investigated the case. Trial Attorney Claire Sobczak Pacelli of the DOJ Fraud Division's Health Care Fraud Section is prosecuting the case.

HHS-OIG Special Agent in Charge Thomas Ethridge stated that the alleged conduct exploited a federal program intended to ensure access to essential COVID-19 testing services for uninsured individuals during the public health emergency.

The indictment contains allegations only, and Patel is presumed innocent unless proven guilty beyond a reasonable doubt.

Implications for Health Care Billing and Federal Program Oversight

The case highlights the importance of accurate billing, patient verification, and documentation in federally funded health care programs.

For clinical laboratories, pharmacies, and other health care organizations participating in government reimbursement programs, the allegations underscore the potential legal consequences of submitting claims for services that were not provided.

The prosecution also illustrates the role of federal enforcement agencies in investigating suspected misuse of emergency health care funding and protecting the integrity of programs designed to expand access to medical services.

As the case proceeds, it reinforces the importance of billing transparency and accountability among health care providers receiving federal reimbursements.

Reference

US Department of Justice Office of Public Affairs. Illinois laboratory owner charged in $66M COVID-19 testing fraud scheme. Press release. Published October 20, 2026. Accessed October 21, 2026. https://www.justice.gov/opa/pr/illinois-laboratory-owner-charged-66m-covid-19-testing-fraud-scheme